Related Experiment Video

Updated: Aug 21, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Adult phenylketonuria

W B Hanley1

  • 1Phenylketonuria Programme, Division of Clinical and Biochemical Genetics, Department of Pediatrics and the Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada. whanley@sickkids.ca

The American Journal of Medicine
|October 7, 2004
PubMed

Insights

Phenylketonuria (PKU) newborn screening enables intellectual development through early diet intervention. However, adults with PKU require specialized lifelong care and support, highlighting a critical need for dedicated adult physicians.

Area of Science:

  • Metabolic disorders
  • Genetics
  • Public health

Background:

  • Newborn screening for phenylketonuria (PKU) has been standard for decades.
  • Early dietary intervention (phenylalanine-restricted diets) has led to improved intellectual outcomes in adults with PKU.
  • Significant numbers of PKU patients reach adulthood annually.

Purpose of the Study:

  • To review the long-term outcomes and ongoing needs of adults with phenylketonuria.
  • To highlight the challenges in adult care for PKU patients.
  • To emphasize the need for specialized medical professionals for adult PKU management.

Main Methods:

  • Review of existing literature and clinical recommendations regarding phenylketonuria management.
  • Analysis of outcomes in adult patients with phenylketonuria.
  • Identification of gaps in adult care provision.

Main Results:

  • Adults with PKU, particularly those with milder forms, may not require strict dietary control post-adolescence for intellectual stability.
  • Neuropsychological and psychosocial issues are prevalent in adult PKU patients.
  • There is a notable scarcity of adult physicians specializing in PKU care.

Conclusions:

  • Lifelong monitoring and support are crucial for adults with phenylketonuria, even if intellectual function is preserved.
  • Addressing neuropsychological and psychosocial challenges requires dedicated healthcare provider involvement.
  • There is an urgent requirement for physicians to lead and coordinate comprehensive adult PKU care.

More Related Videos

Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease12:47

Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease

Published on: February 3, 2012

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pedigree Analysis01:35

Pedigree Analysis

Overview